Skin Cancer Screening

commisiononcancer_accredprog_vertSkin cancer volumes are on the rise. With the goal of early detection, the WVU Cancer Institute offers annual, free skin cancer screening. During this screening, physicians from the WVU Cancer Institute and the WVU Medicine Department of Dermatology provide full body examinations, looking for abnormalities in the skin and using guidelines from the American Academy of Dermatology (AAD).

The 2017 screening took place May 18, and 94 community members attended. All skin abnormalities found as a result of the screening were given a presumptive diagnosis. During the event this year, physicians recommended to 21 participants that they have a biopsy performed. An additional 32 participants were referred to a dermatologist.

The presumptive diagnoses included:

  • Seborrheic Keratosis – 30
  • Actinic Keratosis – 16
  • Basal Cell Carcinoma – 7
  • Squamous Cell Carcinoma – 5
  • Dysplastic Nevus – 15
  • Congenital Nevus – 9
  • Melanoma – 2
  • Moles– 32

Participants of this event also completed a pre-test upon arrival to assess their knowledge of skin cancer prevention.  They were given an ACS Skin Cancer Prevention Infographic to review while they waited and then completed a post-test prior to departure.  The pre-test average was 70% and post-test average was 84% showing an increase in knowledge gained during the screening.

Following the screening, participants received a list of providers and were asked to schedule an appointment with a provider of their choice, as a follow-up to the recommendations given during the screening.

The next skin cancer screening will be announced in early 2018.

Breast Cancer Screening

mother-daughter-bright-beauty-istock_000014673270Breast Cancer is one of the top three cancer diagnoses in West Virginia. Early detection is important, and the WVU Cancer Institute is doing its part by offering a free clinical breast cancer screening.

The next opportunity to participate in the free clinical breast cancer screening event will be announced soon.